Elsevier Inc.

SHERPA: Unknown

People

  1. Ginsberg
    Ginsberg
  2. Kris
    Kris
  3. Miller
    Miller
  4. Riely
    Riely
  5. Dunne
    Dunne
  6. Paik
    Paik
  7. Rusch
    Rusch
  8. Sirotnak
    Sirotnak
  9. Travis
    Travis

Groups

  1. Body Imaging Service (4)
  2. Department of Medicine (4)
  3. Radiology, Department of (4)
  4. Solid Tumor Oncology Division (4)
  5. Thoracic Oncology (4)
  6. Advanced Practice Providers (1)
  7. Nursing (1)
  8. Surgery (1)
  9. Survivorship Research (1)
Search Within
  1. "2011"
  2. "Journal of Thoracic Oncology"
  3. "Body Imaging Service"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (1)
Groups
  1. Body Imaging Service (4)
  2. Department of Medicine (4)
  3. Radiology, Department of (4)
  4. Solid Tumor Oncology Division (4)
  5. Thoracic Oncology (4)
  6. Advanced Practice Providers (1)

More Groups

People
  1. Mark Kris (4)
  2. Michelle Ginsberg (4)
  3. Christopher Azzoli (3)
  4. Naiyer Rizvi (3)
  5. Vincent Miller (3)
  6. Camelia Sima (2)

More People

Years
  1. 2011 (4)
Publications
  1. Journal of Thoracic Oncology (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pralatrexate with vitamin supplementation in patients with previously treated, advanced non-small cell lung cancer: Safety and efficacy in a phase 1 trial
    Journal Article

    Azzoli, C. G.; Patel, J. D.; Krug, L. M.; Miller, V.; James, L.; Kris, M. G.; Ginsberg, M.; Subzwari, S.; Tyson, L.; Dunne, M.; more...
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • A phase II trial of salirasib in patients with lung adenocarcinomas with KRAS mutations
    Journal Article

    Riely, G. J.; Johnson, M. L.; Medina, C.; Rizvi, N. A.; Miller, V. A.; Kris, M. G.; Pietanza, M. C.; Azzoli, C. G.; Krug, L. M.; Pao, W.; more...
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • A window study evaluating the activity of single agent bevacizumab prior to induction chemotherapy for operable non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Paik, P. K.; Oxnard, G. R.; Price, K.; Sima, C. S.; Ginsberg, M. S.; Travis, W. D.; Rusch, V.; Kris, M. G.; Rizvi, N. A.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Phase II trial of dasatinib for patients with acquired resistance to treatment with the epidermal growth factor receptor tyrosine kinase inhibitors erlotinib or gefitinib
    Journal Article

    Johnson, M. L.; Riely, G. J.; Rizvi, N. A.; Azzoli, C. G.; Kris, M. G.; Sima, C. S.; Ginsberg, M. S.; Pao, W.; Miller, V. A.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save